Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries
Open Access
- 1 May 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 18 (5) , 858-859
- https://doi.org/10.1093/ndt/gfg166
Abstract
There are about 1 million people in the world that are alive just because they have access to one form or another of renal replacement therapy (RRT) [1]. Ninety percent of them live in the developed countries, or, as they are defined by the World Bank (WB), high‐income countries, where the average gross income is in excess of $10 000 per capita.Keywords
This publication has 11 references indexed in Scilit:
- CADASIL: A Monogenic Condition Causing Stroke and Subcortical Vascular DementiaCerebrovascular Diseases, 2002
- Global Burden of Cardiovascular DiseasesCirculation, 2001
- Modulating the profit motive to meet needs of the less-developed worldThe Lancet, 2001
- Reflections on the XVth ICN meeting: renal and cardiovascular protection in the developing worldNephrology Dialysis Transplantation, 2001
- Progression, remission, regression of chronic renal diseasesThe Lancet, 2001
- Reducing premature death and renal failure in Australian AboriginalsThe Medical Journal of Australia, 2000
- Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National RegistriesNephrology Dialysis Transplantation, 1999
- Clinical and epidemiological programme on renal disease.Nephrology Dialysis Transplantation, 1999
- Renal epidemiology. The first clinical and epidemiological programme on renal disease in Bolivia: a model for prevention and early diagnosis of renal diseases in the developing countriesNephrology Dialysis Transplantation, 1998
- Evolution of renal replacement therapy in Central and Eastern Europe 7 years after political and economical liberationNephrology Dialysis Transplantation, 1998